Mel Mann shares his inspiring 30-year journey with chronic myeloid leukemia, from a terminal diagnosis to long-term survival.

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

Imatinib, a tyrosine kinase inhibitor of Bcr-Abl, is the current first-line therapy for patients with chronic myelogenous leukemia (CML ... is an effective treatment option that has been approved ...

80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- ... Tumor-Induced B Cell Changes Reveal Potential Biomarker for Treatment Response ...

Frontline tyrosine kinase inhibitors are well-established for chronic myelogenous leukemia, but some patients experience inadequate response or adverse events, highlighting the need for novel ...

Mitochondria are pivotal cellular organelles that play a crucial role in regulating metabolism and cell survival, making them ...

Aucatzyl is a chimeric antigen receptor (CAR) T-cell therapy, a type of therapy that uses genetic modification to train the ...

Alana Kent took to TikTok to list the signs of the condition - which she initially believed would soon resolve - with the ...

Leukemia is a type of cancer that interferes with normal blood clotting and places other stresses on the body, including the skin. A leukemia rash can occur in the early stages when tiny blood vessels ...

shaping cancer cell phenotypes and driving treatment resistance. We harnessed two single-cell multiomics methods to characterize the heterogeneity of acute myeloid leukemia with complex karyotype ...

Anemia is more common in later-stage chronic kidney disease (CKD), with ... anemia if you also have diabetes or are on dialysis treatment. Tell your doctor if you experience symptoms of anemia ...